Patents expiring in 2035

US 9034343

Attenuated human parainfluenza virus, methods and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034323

Method for control of post-prandial glucose

HALOZYME, INC. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034336

Immunomodulators and immunomodulator conjugates

Regents of the University of Minnesota · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034313

Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same

Inovio Pharmaceuticals, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034311

Pyridin-2(1 H)-one derivatives as JAK inhibitors

Almirall, S.A. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9034388

Bioeffective krill oil compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9033919

Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

Lutonix, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040061

Topical formulation for administering a compound

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040522

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040658

Thiol-selective water-soluble polymer derivatives

Nektar Therapeutics · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040059

Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040060

Hydrolytically degradable alkylene oxide based polymers

Nektar Therapeutics · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040721

Halogenated compounds for Photodynamic therapy

NANOQUANTUM SCIENCES, INC. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040626

Nanofibers and morphology shifting micelles

The Regents of the University of California · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040550

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040543

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040567

BAX agonist, compositions, and methods related thereto

The Board of Regents of the University of Texas System · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040542

Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

Vertex Pharmaceuticals Incorporated · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040250

Binding interaction of proanthocyanidins with bacteria and bacterial components

United States of America as represented by the Secretary of the Air Force · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040527

Pyrimidinediamine kinase inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040241

Genetic markers of mental illness

SureGene LLC · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040233

Methods for detecting a Mycobacterium tuberculosis infection

The United States of America, DBA The Department of Veteran Affairs · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9040157

Hollow nanoparticles and nanocomposites and methods of making hollow nanoparticles and nanocomposites

The Board of Regents of the University of Texas System · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2866861

TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

AIR LIQUIDE SANTE INT [FR] · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 2875810

Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung

BIOCODEX [FR] · Granted Wed May 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue May 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 2931112

IMMUNOGENES CONTRE PLUSIEURS POLLENS ET PROCEDES ET UTILISATIONS POUR MODULER LA REPONSE IMMUNITAIRE

LA JOLLA INST ALLERGY & IMMUNOLOGY [US] · Granted Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2015077442

IMMUNOGÈNES DE POLLEN DE GRAMINÉE AINSI QUE PROCÉDÉS ET UTILISATIONS POUR LA MODULATION DE LA RÉPONSE IMMUNITAIRE

JOLLA INST ALLERGY IMMUNOLOG [US] · Granted Thu May 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed May 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045728

Liquid viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045436

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9046529

Prostatitis-associated antigens and methods of use thereof

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045416

WNT protein signalling inhibitors

The Board of Regents of the University of Texas System · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9046520

Serologic correlates of protection against Bacillis anthracis infection

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045742

Recombinant Edwardsiella bacterium

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045752

NKX3-1 saRNA and KLF4 saRNA and uses thereof

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044381

Method for delivering drugs to the brain

Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045526

Compound and method for modulating opioid receptor activity

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045550

Peptides and compositions for prevention of cell adhesion and methods of using same

Tel Hashomer Medical Research, Infrastructure and Services Ltd, the Technology Transfer Company of Chaim · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045494

Orthoester compound

Nektar Therapeutics · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045437

2-aryl-4-quinazolinones and their pharmaceutical compositions

China Medical University · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045474

Compounds and compositions for mitigating tissue damage and lethality

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045443

Nitric oxide donor neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044454

Regulation of microvasculature occlusion

Northwestern University · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9045401

Methods for treating or ameliorating a melanoma and killing melanoma cells

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044518

Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044514

Lipid-peptide-polymer conjugates and nanoparticles thereof

The Regents of the University of California · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044509

Inhibition of HIV infection through chemoprophylaxis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044498

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

US 9044483

Cell death inhibition by macrophage migration inhibitory factor and a binding substance thereto

Takeda Pharmaceutical Company Limited · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)